Merck and Pfizer Collaborate with Dako, an Agilent Technologies Company, on Development of Companion Diagnostic for Investigational anti-PD-L1 Antibody, Avelumab
September 24, 2015 at 17:01 PM EDT
As part of the global strategic alliance between Merck and Pfizer to jointly develop and commercialize avelumab*, an investigational ...
